AON vs STRO · P/E 31, rev $17.18B vs rev $62.0M
Aon PLC (AON) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Aon PLC (AON) is a insurance brokers company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AON revenue for 2025-12-31 was $17.18B. Net income was $3.69B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. AON currently screens at market cap $76.61B and trailing P/E 30.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AON currently screens at market cap $76.61B and trailing P/E 30.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AON and STRO stock pages for the full models.
Not investment advice.